Protection of Rats from CCl4-induced Hepatic Fibrosis with Danshen Powder for Injection

LI Chen,PU Xiao-ping
DOI: https://doi.org/10.3321/j.issn:1003-3734.2006.12.009
2006-01-01
Abstract:Objective:To assess the protective effect of Danshen powder for injection on CCl_4-in- duced hepatic fibrosis in rats.Methods:SD rats were supplemented with phenobarbital(350 mg·L~(-1)) for 2 weeks and then abdominally injected with CCI4(0.04 mL·kg~(-1))once per week for 8 weeks to in- duce rat hepatic fibrosis.The rats with hepatic fibrosis were randomly assigned to one of model or treat- ment groups.The rats was treated with either Danshen powder for injection(100,250 or 500 mg·kg~(-1)) or glucurolactone injection 26.5 mg·kg~(-1)(positive control)per day for 6 weeks in week 5 post CCl_4.The effectiveness was evaluated based on the levels of aspartate transaminase(AST),alanine transaminase (ALT),hepatic hyaluronic acid(HA),laminin(LN),typeⅢprocollagen(PⅢP)before injection and in weeks 2,4 and 6 post injections.Results:Danshen powder for injection significantly reduced the serum levels of AST,ALT,HA,LN and PⅢP of rats(P<0.01~0.05).Conclusion :Danshen pow- der for injection protects rats from CCl_4-induced liver fibrosis.
What problem does this paper attempt to address?